Product Information
SAXAGLIPTIN-METFORMIN ER 5-1,000 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $10.3869 per EA under NDC 00378817793. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
1000; 5 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378817793
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE DIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA205981On Market Since
8/8/2023
Pharmacological Classes
Price Statistics
The NADAC for SAXAGLIPTIN-METFORMIN ER 5-1,000 MG TABLET has been published 115 times since Apr 17, 2024, and over the history we have for it it has risen 15.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.3869 per EA |
|---|---|
| All-time high | $10.6076 (Apr 15, 2026) |
| All-time low | $8.4798 (May 22, 2024) |
| 52-week high | $10.6076 |
| 52-week low | $9.4868 |
| Median price | $9.7944 |
| Average price | $9.7646 |
| Largest weekly change | +11.4% (Jun 19, 2024) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the saxagliptin and metformin market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of SAXAGLIPTIN-METFORMIN ER 5-1,000 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SAXAGLIPTIN-METFORMIN ER 5-1,000 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $10.3869 per EA (NDC 00378817793), effective Jun 24, 2026.
How has the price of SAXAGLIPTIN-METFORMIN ER 5-1,000 MG TABLET changed over time?
Over the history we have for it, the NADAC for SAXAGLIPTIN-METFORMIN ER 5-1,000 MG TABLET has risen 15.9%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for SAXAGLIPTIN-METFORMIN ER 5-1,000 MG TABLET?
Since Apr 17, 2024, the NADAC for SAXAGLIPTIN-METFORMIN ER 5-1,000 MG TABLET has ranged from a low of $8.4798 (May 22, 2024) to a high of $10.6076 (Apr 15, 2026), with a median of $9.7944 per EA.
Are there cheaper alternatives to SAXAGLIPTIN-METFORMIN ER 5-1,000 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of SAXAGLIPTIN-METFORMIN ER 5-1,000 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures SAXAGLIPTIN-METFORMIN ER 5-1,000 MG TABLET?
SAXAGLIPTIN-METFORMIN ER 5-1,000 MG TABLET (NDC 00378817793) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification